Bottom line
What is IRVXX's expense ratio?
IRVXX's expense ratio is 1.05%, or about $105 a year on every $10,000 invested. That is more expensive than 97% of money market funds we track (median 0.32%). It has no front-end sales load. Its expense ratio includes a 0.87% 12b-1 marketing fee.
Updated Dec 18, 2025
IRVXX fee table
| Net expense ratio | 1.05% |
|---|---|
| Gross expense ratio | 1.12% |
| Management fee | 0.25% |
| 12b-1 (distribution) fee | 0.87% |
| Fee waiver / reimbursement | -0.07% |
| Max front-end sales load | 0% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Dec 18, 2025
What IRVXX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| IRVXX | $107 | $349 | $610 | $1,357 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.05% expense ratio costs roughly $57,900 in lost growth, versus about $18,800 for the median money market fund (0.32%).